Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Invested Capital (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Return on Invested Capital for 13 consecutive years, with 7.22% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 730.0% year-over-year to 7.22%, compared with a TTM value of 7.22% through Dec 2025, down 730.0%, and an annual FY2025 reading of 7.44%, down 753.0% over the prior year.
  • Return on Invested Capital was 7.22% for Q4 2025 at Amicus Therapeutics, down from 0.15% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.7% in Q1 2025 and bottomed at 7.22% in Q4 2025.
  • Average Return on Invested Capital over 5 years is 0.53%, with a median of 0.27% recorded in 2021.
  • Peak annual rise in Return on Invested Capital hit 83bps in 2025, while the deepest fall reached -730bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.29% in 2021, then plummeted by -36bps to 0.4% in 2022, then surged by 64bps to 0.15% in 2023, then surged by 158bps to 0.08% in 2024, then tumbled by -8671bps to 7.22% in 2025.
  • Business Quant data shows Return on Invested Capital for FOLD at 7.22% in Q4 2025, 0.15% in Q3 2025, and 0.06% in Q2 2025.